Chief Technical Officer
Current
Oct 2024 - Present
AeroLeads people directory · profile
David Ege, Phd Email & Phone Number
Chief Technical Officer, ADC Therapeutics
at
ADC Therapeutics
1 work email found
@serestherapeutics.com
1 phone found area 908
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Role
Chief Technical Officer, ADC Therapeutics
Location
New York City Metropolitan Area, United States, United States
Who is David Ege, Phd? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
David Ege, Phd is listed as Chief Technical Officer, ADC Therapeutics at ADC Therapeutics, based in New York City Metropolitan Area, United States, United States. AeroLeads shows a work email signal at serestherapeutics.com, phone signal with area code 908, and a matched LinkedIn profile for David Ege, Phd.
David Ege, Phd previously worked as Chief Technical Officer at Adc Therapeutics and Chief Technology Officer & EVP Process Development, Quality & Supply at Seres Therapeutics. David Ege, Phd holds Bse, Chemical Engineering from Princeton University.
Company email context
Email format at ADC Therapeutics
This section adds company-level context without repeating David Ege, Phd's masked contact details.
*@serestherapeutics.com
68% confidence
AeroLeads found 1 current-domain work email signal for David Ege, Phd. Compare company email patterns before reaching out.
Profile bio
About David Ege, Phd
As Chief Technical Officer, my work at ADC Therapeutics is focused on ensuring safe, high-quality manufacturing of our antibody drug-conjugate therapies including Zynlonta. My specialties and interests include manufacturing operations, QA/QC, technical operations, process and analytical development, regulatory CMC, supply chain, and clinical supply. I have played a role in numerous IND and BLA filings, PAI inspections and product launches for biologics, vaccines, immunotherapies and LBPs. Most notably, I contributed to the BLAs, approval and launches of Keytruda, Gardasil and VOWST.I have more than 20 years in the pharmaceutical and biotech field with a focus in oncology, vaccine and biologics manufacturing, and process optimization including at Merck with the successful first-in-class licensure and launch of cervical cancer vaccines, Gardasil® (2006) and Gardasil9® (2014), and the breakthrough cancer immunotherapy, Keytruda® (2014); as well as Seres Therapeutics’ approval of VOWST (2023). All views are my own.
Listed skills include Biopharmaceuticals, Vaccines, Validation, Pharmaceutical Industry, and 25 others.
Current workplace
David Ege, Phd's current company
Company context helps verify the profile and gives searchers a useful next step.
13 roles · 27 years
David Ege, Phd work experience
A career timeline built from the work history available for this profile.
Chief Technology Officer & Evp Process Development, Quality & Supply
As a member of Seres' executive committee, I am helping to lead Seres' efforts to pioneer a new modality of oral microbiome therapeutics by harnessing breakthrough insights on gut health and its influence on diverse disease states. My organization is responsible for process and analytical development, clinical and commercial supply (internal and external).
Oct 2020 - Oct 2024
Digital Strategy Lead - Manufacturing
Merck
Jun 2019 - Oct 2020
Executive Director, Vaccines & Biologics Manufacturing
Merck
Site Operations Lead for Vaccines & Biologics Manufacturing
Apr 2015 - Jun 2019
Head, Commercial Manufacturing Operations
MSD Werthenstein BioPharma GmbHKeytruda (pembrolizumab) commercialization and supply (immuno-oncology, cancer therapeutic).
Jul 2014 - Mar 2015
Director, Biologics Manufacturing
MSD Werthenstein BioPharma GmbHKeytruda (pembrolizumab) commercialization and supply (immuno-oncology, cancer therapeutic).
Sep 2012 - Jun 2014
Director, Vaccines Manufacturing Science & Commercialization
Merck
Department Head - Viral Vaccines Process Development
Jul 2011 - Sep 2012
Associate Director, Vaccines Manufacturing Science & Commercialization
Merck
Apr 2011 - Jul 2011
Manager, Vaccines Manufacturing Science & Commercialization
Merck
Jul 2010 - Apr 2011
Franchise Portfolio Manager, Merck Bioventures
Merck
Pipeline development for new biosimilars business within Merck. Collaborated end-to-end across the enterprise from basic research, through clinical development and process development, to market research, competitive intelligence and business development.
Apr 2008 - Jul 2010
Senior Process Engineer
Merck
Developed and deployed Proactive Process Monitoring, Manufacturing Intelligence (MI), Business Intelligence (BI) Systems for continuous improvement in biologics manufacturing; Led Six Sigma projects for biologics process optimization.
Jun 2007 - Mar 2008
Process Engineer - Gardasil
Merck
New facility start-up for Gardasil manufacturing (technology transfer, qualification, validation, regulatory filing, regulatory pre-approval inspection); Biologics process optimization;
Nov 2003 - May 2007
Co-Founder
Mobido, Inc.
1999 - 2001
~2 yrs
3 education records
David Ege, Phd education
Bse, Chemical Engineering
Princeton University
Phd, Chemical Engineering
University Of Pennsylvania
Education record
University Of Pennsylvania
FAQ
Frequently asked questions about David Ege, Phd
Quick answers generated from the profile data available on this page.
What company does David Ege, Phd work for?
David Ege, Phd works for ADC Therapeutics.
What is David Ege, Phd's role at ADC Therapeutics?
David Ege, Phd is listed as Chief Technical Officer, ADC Therapeutics at ADC Therapeutics.
What is David Ege, Phd's email address?
AeroLeads has found 1 work email signal at @serestherapeutics.com for David Ege, Phd at ADC Therapeutics.
What is David Ege, Phd's phone number?
AeroLeads has found 1 phone signal(s) with area code 908 for David Ege, Phd at ADC Therapeutics.
Where is David Ege, Phd based?
David Ege, Phd is based in New York City Metropolitan Area, United States, United States while working with ADC Therapeutics.
What companies has David Ege, Phd worked for?
David Ege, Phd has worked for Adc Therapeutics, Seres Therapeutics, Merck, Msd, and Mobido, Inc..
How can I contact David Ege, Phd?
You can use AeroLeads to view verified contact signals for David Ege, Phd at ADC Therapeutics, including work email, phone, and LinkedIn data when available.
What schools did David Ege, Phd attend?
David Ege, Phd holds Bse, Chemical Engineering from Princeton University.
What skills is David Ege, Phd known for?
David Ege, Phd is listed with skills including Biopharmaceuticals, Vaccines, Validation, Pharmaceutical Industry, Commercialization, Process Simulation, Manufacturing, and Technology Transfer.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial